Journal of Neuroimmune Pharmacology

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.

《神经免疫药理学杂志》（Journal of Neuroimmune Pharmacology，JNIP）致力于推动神经系统药理学和免疫学领域重要新发现的传播、关注和交流。该杂志与神经免疫药理学会的目标一致，旨在加深对受免疫系统影响或影响免疫系统的神经和神经精神疾病的基本理解，并通过药理学手段改善疾病的预后和治疗。JNIP的发表范围广泛，包括关于神经免疫疾病和受免疫紊乱影响的神经系统疾病的病因、预防和治疗的原创研究和综述文章。特别欢迎那些有助于揭示神经免疫如何调节环境或内源性因素（如毒素、药物滥用、激素和细胞因子）的原创性研究。JNIP旨在成为药理学、免疫学和神经科学领域跨学科信息交流的可靠平台。